Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-05

AUTHORS

Laurent Hauviller, Frédéric Eyvrard, Valérie Garnault, Vanessa Rousseau, L. Molinier, Jean Louis Montastruc, Haleh Bagheri

ABSTRACT

CONTEXT: Adverse drug reactions (ADRs) are responsible for 5 % of hospital admissions, but hospital re-admission induced by ADRs remains poorly documented. OBJECTIVE: The aim of this study was to estimate the rate of hospital re-admission and the factors associated with re-admission in the patients over the age of 65 years. Secondary, we described the characteristics of cases of ADRs leading to re-admission for drugs other than chemotherapy agents. METHODS: Data were extracted from hospital discharge summaries provided by the Department of Medical Information of Toulouse University Hospital. All patients over the age of 65 years admitted to the hospital in 2010 for an ADR, identified from ICD-10 codes, were selected. All subsequent admissions of members of this cohort within 1 year of discharge following the index admission were reviewed retrospectively. The risk factors associated with hospital re-admission for ADRs were analyzed. Medical records were used for descriptive analysis of re-admission due to drugs other than chemotherapy agents. RESULTS: We found that 553 of the 1000 patients admitted for ADRs in 2010 were re-admitted to hospital within 1 year. Among them, 87 cases were re-admitted for ADRs (estimated rate of 87/1000 re-admission for an ADR within 1 year). A comparison of the patients re-admitted for ADRs (n = 87) with those of patients re-admitted for other causes (n = 410) suggested that only cancer increased the risk of re-admission for ADRs (OR = 7.69 [4.59-12.88] 95 % CI). ADRs due to the same drug combination were the suspected cause of repeat admission in half the cases (other than chemotherapy). Hospital re-admission was considered avoidable in four cases (22 %). CONCLUSION: This study shows an estimated rate of re-admission for an ADR around 87/1000 within 1 year, and the same drug combination were the suspected cause of repeat admission in half the cases. At least, 11 % of cases were avoidable. More... »

PAGES

631-639

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00228-016-2022-4

DOI

http://dx.doi.org/10.1007/s00228-016-2022-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005794645

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26884320


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "France", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitals, University", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Readmission", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Service de Pharmacologie M\u00e9dicale et Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d\u2019Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine de l\u2019Universit\u00e9 Paul Sabatier-, INSERM U1027, 37 All\u00e9es Jules Guesde, 31000, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hauviller", 
        "givenName": "Laurent", 
        "id": "sg:person.0656731526.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656731526.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Service de Pharmacologie M\u00e9dicale et Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d\u2019Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine de l\u2019Universit\u00e9 Paul Sabatier-, INSERM U1027, 37 All\u00e9es Jules Guesde, 31000, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eyvrard", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.0773160126.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773160126.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Toulouse", 
          "id": "https://www.grid.ac/institutes/grid.411175.7", 
          "name": [
            "D\u00e9partement d\u2019Informations M\u00e9dicales, CHU Toulouse, H\u00f4tel Dieu St Jacques, 2 Rue Viguerie, 31300, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garnault", 
        "givenName": "Val\u00e9rie", 
        "id": "sg:person.01326455572.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326455572.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Service de Pharmacologie M\u00e9dicale et Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d\u2019Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine de l\u2019Universit\u00e9 Paul Sabatier-, INSERM U1027, 37 All\u00e9es Jules Guesde, 31000, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rousseau", 
        "givenName": "Vanessa", 
        "id": "sg:person.01224425744.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224425744.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Toulouse", 
          "id": "https://www.grid.ac/institutes/grid.411175.7", 
          "name": [
            "D\u00e9partement d\u2019Informations M\u00e9dicales, CHU Toulouse, H\u00f4tel Dieu St Jacques, 2 Rue Viguerie, 31300, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Molinier", 
        "givenName": "L.", 
        "id": "sg:person.01020625607.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020625607.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Service de Pharmacologie M\u00e9dicale et Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d\u2019Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine de l\u2019Universit\u00e9 Paul Sabatier-, INSERM U1027, 37 All\u00e9es Jules Guesde, 31000, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Montastruc", 
        "givenName": "Jean Louis", 
        "id": "sg:person.01275357622.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275357622.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratoire Epid\u00e9miologie et Analyses en Sant\u00e9 Publique : Risques, Maladies Chroniques et Handicaps", 
          "id": "https://www.grid.ac/institutes/grid.464120.5", 
          "name": [
            "Service de Pharmacologie M\u00e9dicale et Clinique, Centre Midi-Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d\u2019Informations sur le M\u00e9dicament, Facult\u00e9 de M\u00e9decine de l\u2019Universit\u00e9 Paul Sabatier-, INSERM U1027, 37 All\u00e9es Jules Guesde, 31000, Toulouse, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bagheri", 
        "givenName": "Haleh", 
        "id": "sg:person.01364573443.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364573443.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s40264-015-0281-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001160740", 
          "https://doi.org/10.1007/s40264-015-0281-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40264-015-0281-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001160740", 
          "https://doi.org/10.1007/s40264-015-0281-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jgs.12037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006486636"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2515/therapie/2015029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007532151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2515/therapie/2015029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007532151"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.329.7456.15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009651897"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.320.7241.1036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010105966"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/fcp.12088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010881175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.2044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011362188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.2044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011362188"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013683180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013683180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015618261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015618261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-014-2160-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015639224", 
          "https://doi.org/10.1007/s00520-014-2160-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.revmed.2014.11.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016263408"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2010.03751.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016947415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2010.03751.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016947415"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.2002.50607.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025736981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2006.02633.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026169649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2006.02633.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026169649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02799-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026617336"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2515/therapie:2005005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028669574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2515/therapie:2005005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028669574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200932050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031235306", 
          "https://doi.org/10.2165/00002018-200932050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200932050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031235306", 
          "https://doi.org/10.2165/00002018-200932050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.a2752", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034121460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jclinepi.2004.03.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037159674"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2010.11.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037759792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.296.15.1858", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038437345"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40264-014-0149-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042552606", 
          "https://doi.org/10.1007/s40264-014-0149-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1q529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045163012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1q529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045163012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1565", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047205993"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074655997", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2515/therapie/2015029", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079125386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080075941", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-05", 
    "datePublishedReg": "2016-05-01", 
    "description": "CONTEXT: Adverse drug reactions (ADRs) are responsible for 5 % of hospital admissions, but hospital re-admission induced by ADRs remains poorly documented.\nOBJECTIVE: The aim of this study was to estimate the rate of hospital re-admission and the factors associated with re-admission in the patients over the age of 65 years. Secondary, we described the characteristics of cases of ADRs leading to re-admission for drugs other than chemotherapy agents.\nMETHODS: Data were extracted from hospital discharge summaries provided by the Department of Medical Information of Toulouse University Hospital. All patients over the age of 65 years admitted to the hospital in 2010 for an ADR, identified from ICD-10 codes, were selected. All subsequent admissions of members of this cohort within 1 year of discharge following the index admission were reviewed retrospectively. The risk factors associated with hospital re-admission for ADRs were analyzed. Medical records were used for descriptive analysis of re-admission due to drugs other than chemotherapy agents.\nRESULTS: We found that 553 of the 1000 patients admitted for ADRs in 2010 were re-admitted to hospital within 1 year. Among them, 87 cases were re-admitted for ADRs (estimated rate of 87/1000 re-admission for an ADR within 1 year). A comparison of the patients re-admitted for ADRs (n = 87) with those of patients re-admitted for other causes (n = 410) suggested that only cancer increased the risk of re-admission for ADRs (OR = 7.69 [4.59-12.88] 95 % CI). ADRs due to the same drug combination were the suspected cause of repeat admission in half the cases (other than chemotherapy). Hospital re-admission was considered avoidable in four cases (22 %).\nCONCLUSION: This study shows an estimated rate of re-admission for an ADR around 87/1000 within 1 year, and the same drug combination were the suspected cause of repeat admission in half the cases. At least, 11 % of cases were avoidable.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00228-016-2022-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "72"
      }
    ], 
    "name": "Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years", 
    "pagination": "631-639", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1b9b2d2b11a744c88e1784e8b3be26a20cf3df6ee47a128cd69a323694893e42"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26884320"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00228-016-2022-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005794645"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00228-016-2022-4", 
      "https://app.dimensions.ai/details/publication/pub.1005794645"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00228-016-2022-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00228-016-2022-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00228-016-2022-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00228-016-2022-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00228-016-2022-4'


 

This table displays all metadata directly associated to this object as RDF triples.

235 TRIPLES      21 PREDICATES      65 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00228-016-2022-4 schema:about N0ddda5b41f94487b8de3df05fa8e849c
2 N1563659e5c6644f791665177b7bae669
3 N1dec9b0816d2444eacf227400f8282d5
4 N1e175bbeb9274c59acd1ba20d496d128
5 N6e72b20e04064cdfb9fc7720999ad442
6 Nae3595b75eae40ae804ea90af4c929f2
7 Naf7750f0cfe747cfb3942b4d63bcee3d
8 Nbc148eea60414748a1bd1aa39007d3d2
9 Nd14c7efc8b0b4a25bd4bcfb3e26a9c8e
10 Neeb3546f70cc4fd1a85033a7f3237a97
11 anzsrc-for:11
12 anzsrc-for:1117
13 schema:author Nc001f0f33adc483799690adc5e992f8e
14 schema:citation sg:pub.10.1007/s00520-014-2160-0
15 sg:pub.10.1007/s40264-014-0149-8
16 sg:pub.10.1007/s40264-015-0281-0
17 sg:pub.10.2165/00002018-200932050-00006
18 https://app.dimensions.ai/details/publication/pub.1074655997
19 https://app.dimensions.ai/details/publication/pub.1080075941
20 https://doi.org/10.1001/jama.296.15.1858
21 https://doi.org/10.1002/pds.1154
22 https://doi.org/10.1002/pds.1565
23 https://doi.org/10.1002/pds.2044
24 https://doi.org/10.1016/j.jclinepi.2004.03.012
25 https://doi.org/10.1016/j.jpainsymman.2010.11.014
26 https://doi.org/10.1016/j.revmed.2014.11.016
27 https://doi.org/10.1016/s0140-6736(00)02799-9
28 https://doi.org/10.1046/j.1532-5415.2002.50607.x
29 https://doi.org/10.1111/fcp.12088
30 https://doi.org/10.1111/j.1365-2125.2006.02633.x
31 https://doi.org/10.1111/j.1365-2125.2010.03751.x
32 https://doi.org/10.1111/jgs.12037
33 https://doi.org/10.1136/bmj.320.7241.1036
34 https://doi.org/10.1136/bmj.329.7456.15
35 https://doi.org/10.1136/bmj.a2752
36 https://doi.org/10.1345/aph.1l037
37 https://doi.org/10.1345/aph.1q529
38 https://doi.org/10.2515/therapie/2015029
39 https://doi.org/10.2515/therapie:2005005
40 schema:datePublished 2016-05
41 schema:datePublishedReg 2016-05-01
42 schema:description CONTEXT: Adverse drug reactions (ADRs) are responsible for 5 % of hospital admissions, but hospital re-admission induced by ADRs remains poorly documented. OBJECTIVE: The aim of this study was to estimate the rate of hospital re-admission and the factors associated with re-admission in the patients over the age of 65 years. Secondary, we described the characteristics of cases of ADRs leading to re-admission for drugs other than chemotherapy agents. METHODS: Data were extracted from hospital discharge summaries provided by the Department of Medical Information of Toulouse University Hospital. All patients over the age of 65 years admitted to the hospital in 2010 for an ADR, identified from ICD-10 codes, were selected. All subsequent admissions of members of this cohort within 1 year of discharge following the index admission were reviewed retrospectively. The risk factors associated with hospital re-admission for ADRs were analyzed. Medical records were used for descriptive analysis of re-admission due to drugs other than chemotherapy agents. RESULTS: We found that 553 of the 1000 patients admitted for ADRs in 2010 were re-admitted to hospital within 1 year. Among them, 87 cases were re-admitted for ADRs (estimated rate of 87/1000 re-admission for an ADR within 1 year). A comparison of the patients re-admitted for ADRs (n = 87) with those of patients re-admitted for other causes (n = 410) suggested that only cancer increased the risk of re-admission for ADRs (OR = 7.69 [4.59-12.88] 95 % CI). ADRs due to the same drug combination were the suspected cause of repeat admission in half the cases (other than chemotherapy). Hospital re-admission was considered avoidable in four cases (22 %). CONCLUSION: This study shows an estimated rate of re-admission for an ADR around 87/1000 within 1 year, and the same drug combination were the suspected cause of repeat admission in half the cases. At least, 11 % of cases were avoidable.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf Na3d46e2cff65465798d9524aae30eaf7
47 Nf3cb1923e3204e5faaf2e6466088624c
48 sg:journal.1054337
49 schema:name Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years
50 schema:pagination 631-639
51 schema:productId N06bf3dbf058444b69d5d292913d4b7a8
52 N7db769ae93bf4cc0838337f3bd27fc62
53 N9ad813e3fae14c49b4f9908f10d29bd8
54 Na1bd6f121f05421aa0f0f5e3ecfde17d
55 Nf7aa5a0c049f4a8490de38d5f515d9bc
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005794645
57 https://doi.org/10.1007/s00228-016-2022-4
58 schema:sdDatePublished 2019-04-10T19:08
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Nd710b7ca92e348fc9836552eceed7b24
61 schema:url http://link.springer.com/10.1007%2Fs00228-016-2022-4
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N06bf3dbf058444b69d5d292913d4b7a8 schema:name dimensions_id
66 schema:value pub.1005794645
67 rdf:type schema:PropertyValue
68 N0ddda5b41f94487b8de3df05fa8e849c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Patient Readmission
70 rdf:type schema:DefinedTerm
71 N1563659e5c6644f791665177b7bae669 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Retrospective Studies
73 rdf:type schema:DefinedTerm
74 N1dec9b0816d2444eacf227400f8282d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Aged
76 rdf:type schema:DefinedTerm
77 N1e175bbeb9274c59acd1ba20d496d128 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Male
79 rdf:type schema:DefinedTerm
80 N220cf42372e64d0f98f37c9fc83642bf rdf:first sg:person.01275357622.51
81 rdf:rest N3c07e928b3934bec8722a4f898080e8b
82 N3c07e928b3934bec8722a4f898080e8b rdf:first sg:person.01364573443.33
83 rdf:rest rdf:nil
84 N6e72b20e04064cdfb9fc7720999ad442 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Drug-Related Side Effects and Adverse Reactions
86 rdf:type schema:DefinedTerm
87 N7db769ae93bf4cc0838337f3bd27fc62 schema:name doi
88 schema:value 10.1007/s00228-016-2022-4
89 rdf:type schema:PropertyValue
90 N83ceaca3403b422cbff94874723cd7db rdf:first sg:person.01224425744.21
91 rdf:rest Na1477e6ee0df4815980771dc49751c0f
92 N97ac9ce33b50441abb3183012d0c5609 rdf:first sg:person.01326455572.25
93 rdf:rest N83ceaca3403b422cbff94874723cd7db
94 N9916eafe466b4095a3654257153f08e2 rdf:first sg:person.0773160126.06
95 rdf:rest N97ac9ce33b50441abb3183012d0c5609
96 N9ad813e3fae14c49b4f9908f10d29bd8 schema:name nlm_unique_id
97 schema:value 1256165
98 rdf:type schema:PropertyValue
99 Na1477e6ee0df4815980771dc49751c0f rdf:first sg:person.01020625607.96
100 rdf:rest N220cf42372e64d0f98f37c9fc83642bf
101 Na1bd6f121f05421aa0f0f5e3ecfde17d schema:name pubmed_id
102 schema:value 26884320
103 rdf:type schema:PropertyValue
104 Na3d46e2cff65465798d9524aae30eaf7 schema:issueNumber 5
105 rdf:type schema:PublicationIssue
106 Nae3595b75eae40ae804ea90af4c929f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Female
108 rdf:type schema:DefinedTerm
109 Naf7750f0cfe747cfb3942b4d63bcee3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name France
111 rdf:type schema:DefinedTerm
112 Nbc148eea60414748a1bd1aa39007d3d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Humans
114 rdf:type schema:DefinedTerm
115 Nc001f0f33adc483799690adc5e992f8e rdf:first sg:person.0656731526.59
116 rdf:rest N9916eafe466b4095a3654257153f08e2
117 Nd14c7efc8b0b4a25bd4bcfb3e26a9c8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Aged, 80 and over
119 rdf:type schema:DefinedTerm
120 Nd710b7ca92e348fc9836552eceed7b24 schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 Neeb3546f70cc4fd1a85033a7f3237a97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hospitals, University
124 rdf:type schema:DefinedTerm
125 Nf3cb1923e3204e5faaf2e6466088624c schema:volumeNumber 72
126 rdf:type schema:PublicationVolume
127 Nf7aa5a0c049f4a8490de38d5f515d9bc schema:name readcube_id
128 schema:value 1b9b2d2b11a744c88e1784e8b3be26a20cf3df6ee47a128cd69a323694893e42
129 rdf:type schema:PropertyValue
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
134 schema:name Public Health and Health Services
135 rdf:type schema:DefinedTerm
136 sg:journal.1054337 schema:issn 0031-6970
137 1432-1041
138 schema:name European Journal of Clinical Pharmacology
139 rdf:type schema:Periodical
140 sg:person.01020625607.96 schema:affiliation https://www.grid.ac/institutes/grid.411175.7
141 schema:familyName Molinier
142 schema:givenName L.
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01020625607.96
144 rdf:type schema:Person
145 sg:person.01224425744.21 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
146 schema:familyName Rousseau
147 schema:givenName Vanessa
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224425744.21
149 rdf:type schema:Person
150 sg:person.01275357622.51 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
151 schema:familyName Montastruc
152 schema:givenName Jean Louis
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01275357622.51
154 rdf:type schema:Person
155 sg:person.01326455572.25 schema:affiliation https://www.grid.ac/institutes/grid.411175.7
156 schema:familyName Garnault
157 schema:givenName Valérie
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326455572.25
159 rdf:type schema:Person
160 sg:person.01364573443.33 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
161 schema:familyName Bagheri
162 schema:givenName Haleh
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364573443.33
164 rdf:type schema:Person
165 sg:person.0656731526.59 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
166 schema:familyName Hauviller
167 schema:givenName Laurent
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656731526.59
169 rdf:type schema:Person
170 sg:person.0773160126.06 schema:affiliation https://www.grid.ac/institutes/grid.464120.5
171 schema:familyName Eyvrard
172 schema:givenName Frédéric
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773160126.06
174 rdf:type schema:Person
175 sg:pub.10.1007/s00520-014-2160-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015639224
176 https://doi.org/10.1007/s00520-014-2160-0
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/s40264-014-0149-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042552606
179 https://doi.org/10.1007/s40264-014-0149-8
180 rdf:type schema:CreativeWork
181 sg:pub.10.1007/s40264-015-0281-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001160740
182 https://doi.org/10.1007/s40264-015-0281-0
183 rdf:type schema:CreativeWork
184 sg:pub.10.2165/00002018-200932050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031235306
185 https://doi.org/10.2165/00002018-200932050-00006
186 rdf:type schema:CreativeWork
187 https://app.dimensions.ai/details/publication/pub.1074655997 schema:CreativeWork
188 https://app.dimensions.ai/details/publication/pub.1080075941 schema:CreativeWork
189 https://doi.org/10.1001/jama.296.15.1858 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038437345
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1002/pds.1154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013683180
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1002/pds.1565 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047205993
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1002/pds.2044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011362188
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/j.jclinepi.2004.03.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037159674
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/j.jpainsymman.2010.11.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037759792
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/j.revmed.2014.11.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016263408
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s0140-6736(00)02799-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026617336
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1046/j.1532-5415.2002.50607.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025736981
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1111/fcp.12088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010881175
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1111/j.1365-2125.2006.02633.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026169649
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1111/j.1365-2125.2010.03751.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016947415
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1111/jgs.12037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006486636
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1136/bmj.320.7241.1036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010105966
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1136/bmj.329.7456.15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009651897
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1136/bmj.a2752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034121460
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1345/aph.1l037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015618261
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1345/aph.1q529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045163012
224 rdf:type schema:CreativeWork
225 https://doi.org/10.2515/therapie/2015029 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007532151
226 https://app.dimensions.ai/details/publication/pub.1079125386
227 rdf:type schema:CreativeWork
228 https://doi.org/10.2515/therapie:2005005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028669574
229 rdf:type schema:CreativeWork
230 https://www.grid.ac/institutes/grid.411175.7 schema:alternateName Centre Hospitalier Universitaire de Toulouse
231 schema:name Département d’Informations Médicales, CHU Toulouse, Hôtel Dieu St Jacques, 2 Rue Viguerie, 31300, Toulouse, France
232 rdf:type schema:Organization
233 https://www.grid.ac/institutes/grid.464120.5 schema:alternateName Laboratoire Epidémiologie et Analyses en Santé Publique : Risques, Maladies Chroniques et Handicaps
234 schema:name Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’Informations sur le Médicament, Faculté de Médecine de l’Université Paul Sabatier-, INSERM U1027, 37 Allées Jules Guesde, 31000, Toulouse, France
235 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...